title: Impact of regulation on contact dermatitis.
abstract: Contact dermatitis is a serious public health and dermatologic concern. The prevalence of contact dermatitis in the United States was estimated to be 13.6 per 1000 population according to the National Health and Nutritional Examination Survey using physical examinations by dermatologists of a selected sample of Americans. The American Medical Care Survey estimated that for all American physicians dermatitis is the second most common dermatologic diagnosis proffered. It is essential that government, industry, and dermatologists work together to enhance regulatory methods to control and prevent contact allergy epidemics. Increased knowledge and awareness of occupational skin diseases by dermatologists and other health care professionals will assist in achieving national public health goals. This article reviews governmental regulations-some helpful for patients and workers and some not helpful for dermatologists in their quest to assist patients with contact dermatitis.
authors: NOVA Southeastern University, Largo, FL, USA.
authors: Daniel
authors: D
authors: Hogan
authors: Johnathan J
authors: JJ
authors: Ledet
mesh_terms: D000485:Allergens; D002840:Chromates; D004396:Coloring Agents; D003358:Cosmetics; D003877:Dermatitis, Contact / Q000175:diagnosis / Q000517:prevention & control*; D009783:Dermatitis, Occupational / Q000517:prevention & control; D004781:Environmental Exposure / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D008670:Metals; D016273:Occupational Exposure / Q000331:legislation & jurisprudence / Q000517:prevention & control; D010328:Patch Tests / Q000295:instrumentation; D010655:Phenylenediamines; D011310:Preservatives, Pharmaceutical; D011356:Product Labeling / Q000331:legislation & jurisprudence; D012955:Societies, Medical; D014481:United States
chemical_list: D000485:Allergens; D002840:Chromates; D004396:Coloring Agents; D003358:Cosmetics; D008670:Metals; D010655:Phenylenediamines; D011310:Preservatives, Pharmaceutical; C029728:4-phenylenediamine